Expertise in
19
conditions

Agustin Albillos

Madrid, MD, ES 
Expertise in
19
conditions
Madrid, MD, ES 

Overview

Agustin Albillos practices practicing medicine in Madrid, Spain.

Mr. Albillos is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Portal Hypertension, Ascites, Cirrhosis, Liver Transplant, and Endoscopy.

He is actively involved in clinical research, co-authoring 259 peer reviewed articles and participating in 8 clinical trials.

Gender

Male

Locations

Madrid, MD, Spain
Other Locations
Alcala De Henares, MD, Spain
Alcala Del Rio, AN, Spain
Spain
Barcelona, CT, Spain
Alcala De Xivert, VC, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
Clinical Study of the BreathID® LF System to Train the Algorithm for the ¹³C-Methacetin Breath Test (MBT) in Assessment of Portal Hypertension in Patients With Compensated Liver Cirrhosis
Clinical Study of the BreathID® LF System to Train the Algorithm for the ¹³C-Methacetin Breath Test (MBT) in Assessment of Portal Hypertension in Patients With Compensated Liver Cirrhosis
Enrollment Status: Completed
Publish Date: December 20, 2022
Intervention Type: Device
Study Phase: Not Applicable
A 52-week, Placebo-controlled, Randomized, Phase 3 Study to Evaluate the Safety and Efficacy of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
A 52-week, Placebo-controlled, Randomized, Phase 3 Study to Evaluate the Safety and Efficacy of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
Enrollment Status: Completed
Publish Date: August 02, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Assess the Efficacy & Safety of Oral GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid and With Persistently Elevated Alkaline Phosphatase
A Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Assess the Efficacy & Safety of Oral GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid and With Persistently Elevated Alkaline Phosphatase
Enrollment Status: Completed
Publish Date: June 29, 2022
Intervention Type: Drug
Study Phase: Phase 2
A Phase II, Single-arm, Open-label Study to Characterise the Effect on Portal Pressure, the Effect on Renal Function and the Pharmacokinetic Profile of N-003 in Patients With Decompensated Cirrhosis
A Phase II, Single-arm, Open-label Study to Characterise the Effect on Portal Pressure, the Effect on Renal Function and the Pharmacokinetic Profile of N-003 in Patients With Decompensated Cirrhosis
Enrollment Status: Terminated
Publish Date: February 26, 2021
Intervention Type: Drug
Study Phase: Phase 2
Supplemental Corticosteroids in Cirrhotic Hypotensive Patients With Suspicion of Sepsis
Supplemental Corticosteroids in Cirrhotic Hypotensive Patients With Suspicion of Sepsis
Enrollment Status: Terminated
Publish Date: January 22, 2021
Intervention Type: Drug
Study Phase: Phase 3
Effect of Beta-adrenergic Blockers on Cardiac Function, Systemic and Splanchnic Haemodynamic and Kidney Function in Cirrhotic Patiets With Refractory Ascites
Effect of Beta-adrenergic Blockers on Cardiac Function, Systemic and Splanchnic Haemodynamic and Kidney Function in Cirrhotic Patiets With Refractory Ascites
Enrollment Status: Completed
Publish Date: February 11, 2019
Multicenter, Randomized, Double-blind, Placebo-controlled Study on the Effectiveness of Treatment With Beta-blockers to Prevent Decompensation of Cirrhosis With Portal Hypertension
Multicenter, Randomized, Double-blind, Placebo-controlled Study on the Effectiveness of Treatment With Beta-blockers to Prevent Decompensation of Cirrhosis With Portal Hypertension
Enrollment Status: Completed
Publish Date: August 22, 2017
Intervention Type: Drug
Study Phase: Phase 4
View 7 Less Clinical Trials

259 Total Publications

Impact factor enshittification: Reflections on metrics, incentives and scientific publishing.
Impact factor enshittification: Reflections on metrics, incentives and scientific publishing.
Journal: Annals of hepatology
Published: July 10, 2026

Frequently Asked Questions about Agustin Albillos

Is Agustin Albillos a top-rated expert for Portal Hypertension?

MediFind is an objective health platform that identifies experts based on real-world data. Agustin Albillos is classified as an Elite expert for Portal Hypertension, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Agustin Albillos participate in research or clinical trials?

Yes. Agustin Albillos has published 259 articles and abstracts on conditions like Portal Hypertension. You can view a list of Agustin Albillos's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Albillos's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 52 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile